Investigation of probiotics in multiple sclerosis
None of the disease-modifying therapies (DMTs) currently being used for the management of multiple sclerosis (MS) are 100% effective. In addition, side effects associated with the use of these DMTs have limited the practice of combination therapy. Hence, there is a need for safe immunomodulatory age...
Saved in:
| Published in: | Multiple sclerosis Vol. 24; no. 1; p. 58 |
|---|---|
| Main Authors: | , , , , , , , , , , , |
| Format: | Journal Article |
| Language: | English |
| Published: |
England
01.01.2018
|
| Subjects: | |
| ISSN: | 1477-0970, 1477-0970 |
| Online Access: | Get more information |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Be the first to leave a comment!